It would appear that President Donald Trump is taking longer than Bush and Obama to announce a nominee to head the Justice Department’s antitrust division reports Bloomberg.
The decision should come soon as it will shape the administration’s antitrust policy and determine the fate of several pending mega-deals writes Liz Crampton. The DOJ’s antitrust division has several open investigations into pending mergers that began in former President Barack Obama’s administration, such as Dow Chemical’s purchase of DuPont and AT&T’s bid for Time Warner.
Trump’s nominee will also be the administration’s key decision-maker in bringing lawsuits about companies’ anticompetitive behavior.
The delay in naming an antitrust official means policy decisions about competition could be pushed into the summer. It could be several months after Trump names his pick before that person can actually get to work because the Senate will need to confirm the nominee. But it’s not unusual for new administrations to wait on positions like this.
Crampton says officials don’t tend to stay in the position for very long. In the last four administrations, the longest tenure of the first antitrust assistant attorney general was about three years.
Full Content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas